Category: Healthcare

  • Catecholamine Market

    —

    by

    The global catecholamine market is set to experience substantial growth, with its valuation projected to increase from USD 4.6 billion in 2024 to USD 10.3 billion by 2034.

  • Catheter Market

    —

    by

    The global catheter market is anticipated to grow significantly, reaching USD 24.3 billion by 2034, up from USD 13.6 billion in 2024, with a projected CAGR of 7.3%.

  • Catheter-Associated Urinary Tract Infections (CAUTI) Treatment Market

    —

    by

    The global catheter-associated urinary tract infections (CAUTI) treatment market is anticipated to grow from USD 1.32 billion in 2024 to USD 1.86 billion by 2034, reflecting a CAGR of 4.0% during the forecast period.

  • Catheter-Directed Thrombolysis Market

    —

    by

    The global catheter-directed thrombolysis (CDT) market is anticipated to experience robust growth, increasing from USD 455.8 million in 2024 to USD 809 million by 2034

  • Catheter-Related Bloodstream Infection (CRBSI) Treatment Market

    —

    by

    The global catheter-related bloodstream infection (CRBSI) treatment market is projected to grow from USD 1.54 billion in 2024 to USD 2.87 billion by 2034, demonstrating a robust CAGR of 6.6% during the forecast period.

  • Celiac Disease Diagnostics Market

    —

    by

    The global celiac disease diagnostics market is projected to grow from USD 293.8 million in 2024 to USD 648.3 million by 2034, reflecting a strong CAGR of 8.4% over the forecast period.

  • Cell and Gene Therapy Clinical Trial Market

    —

    by

    The global cell and gene therapy clinical trial market is forecasted to grow exponentially, with an estimated market value increasing from USD 13.2 billion in 2024 to USD 120.3 billion by 2034, representing a robust CAGR of 25.9% during the forecast period.

  • Cell Therapy Growth Factor Market

    —

    by

    The global cell therapy growth factor market is set to expand significantly over the next decade, reaching an estimated value of USD 765.8 million by 2024 and further growing to approximately USD 2.37 billion by 2034, with a robust CAGR of 8.5%.

  • Cell Therapy Manufacturing Market

    —

    by

    The global cell therapy manufacturing market is set to reach an estimated valuation of USD 5,134.48 million in 2024, with robust growth projected at a CAGR of 15.2%

  • Cell-Free Cartilage Repair Market

    —

    by

    The global cell-free cartilage repair market is projected to grow significantly in the next decade, driven by the increasing prevalence of joint disorders and advancements in regenerative medicine. Valued at USD1.03 billion in 2024, the market is expected to reach USD 2.19 billion by 2034, growing at a CAGR of 8.4%